These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6161479)

  • 1. Inhibition of vesicular stomatitis virus transcriptase in vitro by phosphonoformate and ara-ATP.
    Chanda PK; Banerjee AK
    Virology; 1980 Dec; 107(2):562-6. PubMed ID: 6161479
    [No Abstract]   [Full Text] [Related]  

  • 2. RNA polymerase: potent linear competitive inhibition by D arabinose-5-triphosphate compared to non-inhibition by 5' ara-ATP.
    Dennis D; Jurgensen S; Sylvester J
    Biochem Biophys Res Commun; 1980 May; 94(1):205-10. PubMed ID: 6155916
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus.
    Villarreal LP; Holland JJ
    Nat New Biol; 1973 Nov; 246(149):17-9. PubMed ID: 4357167
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of nuclear envelope nucleoside triphosphatase-regulated nucleocytoplasmic messenger RNA translocation by 9-beta-D-arabinofuranosyladenine 5'-triphosphate in rodent cells.
    Schröder HC; Nitzgen DE; Bernd A; Kurelec B; Zahn RK; Gramzow M; Müller WE
    Cancer Res; 1984 Sep; 44(9):3812-9. PubMed ID: 6204747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    Antimicrob Agents Chemother; 1981 Jan; 19(1):44-50. PubMed ID: 6166246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.
    Carroll AR; Wagner RR
    J Virol; 1979 Jan; 29(1):134-42. PubMed ID: 219213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of interference of trisodium phosphonoformate (INN: foscarnet sodium), with influenza virus mRNA synthesis.
    Stridh S; Datema R
    Virology; 1984 May; 135(1):293-6. PubMed ID: 6233785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
    Schnürer J; Oberg B
    Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
    Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of trisodium phosphonoformate on the mean plaque size of pseudorabies virus, infectious bovine rhinotracheitis virus and pigeon herpesvirus.
    Schwers A; Pastoret PP; Vindevogel H; Leroy P; Aguilar-Setien A; Godart M
    J Comp Pathol; 1980 Oct; 90(4):625-33. PubMed ID: 6268670
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
    Margalith M; Falk H; Panet A
    Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS; Plunkett W
    Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium phosphonoformate on blood group antibody detection.
    Douglas R
    Vox Sang; 1987; 53(1):61. PubMed ID: 2958968
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
    Frank KB; Cheng YC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate.
    Muratore O; Varnier OE; Raffanti SP; Schito GC
    Eur J Clin Microbiol; 1984 Oct; 3(5):447-9. PubMed ID: 6238823
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
    Thiel KD; Wutzler P; Sprössig M; Bertram D
    Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of L and NS proteins of vesicular stomatitis virus with its template ribonucleoprotein during RNA synthesis in vitro.
    Thornton GB; De BP; Banerjee AK
    J Gen Virol; 1984 Mar; 65 ( Pt 3)():663-8. PubMed ID: 6199459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.